Amgen Files Proxy Statement for Annual Meeting

TL;DR

Amgen's proxy statement is out, shareholders vote on directors & pay soon.

AI Summary

Amgen Inc. filed a Definitive Proxy Statement (DEFA14A) on May 10, 2024, for its annual shareholder meeting. The filing details the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company leadership and governance matters at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a standard proxy filing detailing routine corporate governance and shareholder voting matters.

Key Players & Entities

• AMGEN INC (company) — Registrant
• 0001193125-24-136137 (filing_id) — Accession Number
• 20240510 (date) — Filing Date
• ONE AMGEN CENTER DRIVE (address) — Business Address
• THOUSAND OAKS (city) — Business Address City
• CA (state) — Business Address State
• 91320 (zip_code) — Business Address Zip
• 001-37702 (filing_number) — SEC File Number

FAQ

From the Filing

0001193125-24-136137.txt : 20240510 0001193125-24-136137.hdr.sgml : 20240510 20240510160231 ACCESSION NUMBER: 0001193125-24-136137 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 24934669 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 DEFA14A 1 d817289ddefa14a.htm DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ☑  Filed by the registrant      ☐  Filed by a party other than the registrant Check the appropriate box:     ☐      Preliminary Proxy Statement ☐   CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2)) ☐   Definitive Proxy Statement ☑   Definitive Additional Materials ☐   Soliciting Material Pursuant to Section 240.14a-12 AMGEN INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of filing fee (check the appropriate box):     ☑      No fee required. ☐   Fee paid previously with preliminary materials. ☐   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0- 11. YOUR VOTE IS IMPORTANT PLEASE VOTE YOUR PROXY TODAY Dear Valued Amgen Stockholder: You should have received your proxy materials in connection with the Amgen Inc. Annual Meeting of Stockholders to be held on May 31, 2024. According to our latest records, your vote instruction for this meeting has not yet been received. Your vote is extremely important, no matter how many shares you hold. If you have not yet voted, please vote today. If you have received more than one notice, proxy card, or voting instruction form, it means that you hold shares that are registered in more than one account. To ensure that all of your shares are voted, please sign and return each card or, if you elect to vote by telephone or Internet, submit one proxy for each notice, proxy card, or voting instruction form that you receive. Please vote as soon as possible by following the instructions below. For the reasons set forth in the 2024 Proxy Statement, dated April 17, 2024, the Board of Directors recommends that you vote: Item 1: “ FOR ” each director nominee; Item 2: “ FOR ” the advisory vote to approve our executive compensation; Item 3: “ FOR ” our Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan; and Item 4: “ FOR ” the ratification of Ernst & Young LLP as our independent registered public accountants. We urge you to review the proxy materials at www.proxyvote.com and vote your shares promptly even if you plan to attend the Annual Meeting of Stockholders. THREE EASY WAYS TO VOTE Vote by telephone or online until 11:59 P.M. Eastern Time on May 28, 2024 for shares held in plans sponsored by Amgen or its subsidiaries and by 11:59 P.M. Eastern Time on May 30, 2024 for shares held directly. If your proxy has already been voted, you do not need to vote again and please disregard this letter. We appreciate your support and continuing interest in Amgen Inc. Thank yo